Estrella Immunopharma, Inc. (ESLA)

Estrella Immunopharma Statistics

Total Valuation

ESLA has a market cap or net worth of $60.95 million. The enterprise value is $59.33 million.

Market Cap	60.95M
Enterprise Value	59.33M

Important Dates

The next estimated earnings date is Thursday, February 26, 2026, before market open.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

ESLA has 42.03 million shares outstanding. The number of shares has increased by 2.36% in one year.

Current Share Class	42.03M
Shares Outstanding	42.03M
Shares Change (YoY)	+2.36%
Shares Change (QoQ)	+2.57%
Owned by Insiders (%)	1.91%
Owned by Institutions (%)	1.73%
Float	17.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.15

Current Ratio	0.15
Quick Ratio	0.12
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	137.32%
Weighted Average Cost of Capital (WACC)	7.28%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-636
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +32.42% in the last 52 weeks. The beta is 0.55, so ESLA's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	+32.42%
50-Day Moving Average	1.44
200-Day Moving Average	1.29
Relative Strength Index (RSI)	59.94
Average Volume (20 Days)	396,917

Short Selling Information

The latest short interest is 864,470, so 2.06% of the outstanding shares have been sold short.

Short Interest	864,470
Short Previous Month	738,819
Short % of Shares Out	2.06%
Short % of Float	4.97%
Short Ratio (days to cover)	0.17

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-13.51M
Pretax Income	-13.51M
Net Income	-13.51M
EBITDA	n/a
EBIT	-13.51M
Earnings Per Share (EPS)	-$0.37

Balance Sheet

The company has $1.63 million in cash and $4,000 in debt, with a net cash position of $1.62 million or $0.04 per share.

Cash & Cash Equivalents	1.63M
Total Debt	4,000
Net Cash	1.62M
Net Cash Per Share	$0.04
Equity (Book Value)	-9.84M
Book Value Per Share	-0.26
Working Capital	-11.34M

Cash Flow

Operating Cash Flow	-1.09M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ESLA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.36%
Shareholder Yield	-2.36%
Earnings Yield	-22.16%
FCF Yield	n/a

Analyst Forecast

The average price target for ESLA is $8.00, which is 451.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	451.72%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1